---
title: APOE – a genetic marker of comorbidity in subjects with morbid obesity
type: pub
encoding: UTF-8

---
<h1>Publikasjon</h1>
<article id="csl-bib-container-LIVRTS4N" class="csl-bib-container">
  <div class="csl-bib-body"> <div class="csl-entry">Farup, P. G., Rootwelt, H., &#38; Hestad, K. (2020). APOE – a genetic marker of comorbidity in subjects with morbid obesity. <i>BMC Medical Genetics</i>, <i>21</i>(146), 1–9. <a href="https://doi.org/10.1186/s12881-020-01082-2">https://doi.org/10.1186/s12881-020-01082-2</a></div> </div>
  <div class="csl-bib-buttons">
    <a href="#taxonomy-article-LIVRTS4N" alt="archive" class="csl-bib-button">Arkiv</a>
    <a href="https://app.cristin.no/results/show.jsf?id=1824333" alt="Cristin" class="csl-bib-button">Cristin</a>
    <a href="http://zotero.org/groups/5881554/items/LIVRTS4N" alt="Zotero" class="csl-bib-button">Zotero</a>
    <a href="#keywords-article-LIVRTS4N" alt="keywords" class="csl-bib-button">Emneord</a>
    <a href="#about-article-LIVRTS4N" alt="about_pub" class="csl-bib-button">Om</a>
    <a href="#sdg-article-LIVRTS4N" alt="sdg" class="csl-bib-button">Berekraftsmål</a>
    <a href="https://bmcmedgenet.biomedcentral.com/track/pdf/10.1186/s12881-020-01082-2" alt="Unpaywall" class="csl-bib-button">Unpaywall</a>
    <a href="https://bmcmedgenet.biomedcentral.com/track/pdf/10.1186/s12881-020-01082-2" alt="EZproxy" class="csl-bib-button">EZproxy</a>
  </div>
  <div id="csl-bib-meta-container-LIVRTS4N"></div>
</article>
<div id="csl-bib-meta-LIVRTS4N" class="csl-bib-meta">
  <article id="about-article-LIVRTS4N" class="about_pub-article">
    <h1>Om</h1>
    Farup et al. gjennomførte ein studie for å undersøke samanhengen mellom genetiske markørar kalla APOE allelar og helseproblem hos personar med alvorleg fedme. Dei følgde 140 individ som gjennomgjekk vekttapsbehandling og bariatrisk kirurgi. Studien fann at ein spesifikk allel, E2, var knytt til betringar i ulike mentale og fysiske helseproblem, som smerte og utmatting. I tillegg observerte dei endringar i CRP, ein markør for inflammasjon, der E2 var assosiert med lågare CRP-nivå og E4 med høgare nivå. Desse funna tyder på at visse genetiske faktorar kan påverke korleis fedme påverkar helsa og korleis individ responderer på vekttapsbehandlingar, og framhevar potensialet for personleg tilpassa medisinske tilnærmingar basert på genetiske profilar.
  </article>
  <article id="keywords-article-LIVRTS4N" class="keywords-article">
    <h1>Emneord</h1>
    APOE, CRP, Komorbiditet, Inflammasjon, Fedme, Psykosomatiske lidingar
  </article>
  <article id="abstract-article-LIVRTS4N" class="abstract-article">
    <h1>Samandrag</h1>
    Background: In population-based studies, the genetic variability of the APOE E alleles have been associated with health outcomes. Health problems are common in subjects with obesity. This study explored associations between the APOE E alleles and comorbidity in subjects with morbid obesity. 
 
Methods: The study included consecutive subjects referred for evaluation of bariatric surgery with morbid obesity (defined as BMI > 40 or > 35 kg/m2 with complications related to obesity). The subjects followed a conservative weight loss program for 6 months before surgery and had a follow-up visit 12 months after surgery. Demographic data and a set psychosomatic scores (musculoskeletal pain, WHO-5 Well-Being Index, Rosenberg Self-Esteem Scale, Hopkins Symptom Check-list 10; Epworth Sleepiness Scale, and Fatigue Severity Scale) were collected, and blood samples were analysed for haematological and biochemical parameters and APOE alleles. 
 
Results: One hundred and forty subjects (men/women: 32 (23%)/108 (77%) with mean age 43.0 (SD 8.7) years and BMI 42.1 (SD 3.8) kg/m2 were included. One hundred and eight and 92 subjects had data after conservative treatment and 12 months after surgery, respectively. The prevalence of the APOE alleles were: E2E2: 1 (0.7%), E2E3: 13 (9.3%), E2E4: 4 (2.9%), E3E3: 71 (50.7%), E3E4: 47 (33.6%), and E4E4: 4 (2.9%). The prevalence rates were as anticipated in a Norwegian population. The weight loss during conservative treatment and after bariatric surgery was independent of E allele variability. E2 was associated with a significant or clear trend toward improvement of all psychosomatic disorders. There was a significant fall in CRP during the two treatment periods with weight loss. E2 and E4 were significantly associated with high and low CRP, respectively, but no associations were seen between CRP and comorbidity. 
 
Conclusions: The most marked finding was the association between E2 and improvement of all psychosomatic disorders. The positive and negative associations between CRP and E2 and E4, respectively, could indicate effects on inflammation and immunological reactions. 
 
Keywords: APOE; CRP; Comorbidity; Inflammation; Obesity; Psychosomatic disorders.
  </article>
  <article id="sdg-article-LIVRTS4N" class="sdg-article">
    <h1>Berekraftsmål</h1>
    <div class="sdg-container"><div id="sdg3" class="sdg">
        <img src="{{< params subfolder >}}images/sdg/sdg03_nn.png" class="image" alt="SDG 3">
        <div class="sdg-overlay">
          <a href="{{< params subfolder >}}nn/archive/?sdg=3#archive" class="sdg-publication-count"><span>1377</span> publikasjonar</a>
          <p><a href="https://fn.no/om-fn/fns-baerekraftsmaal/god-helse-og-livskvalitet?lang=nno-NO" class="sdg-read-more">Les meir</a></p>
        </div>
      </div></div>
  </article>
  <article id="taxonomy-article-LIVRTS4N" class="taxonomy-article">
    <h1>Arkiv</h1>
    <ul>
      <li><a href="{{< params subfolder >}}nn/archive/?key=3DCRN523">Universitetet i Innlandet</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=IDKFS3MX">Fakultet for helse- og sosialvitenskap</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=GTV4ECMZ">Institutt for helse- og sykepleievitenskap</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=LNJIKLR2">2020</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=MCAHBVNW">August</a></li>
    </ul>
  </article>
</div>
